The recommended treatments for stage IV EGFR-positive lung cancer are EGFR-tyrosine kinase inhibitor (TKI) monotherapy, EGFR-TKI plus cytotoxic combination chemotherapy, and EGFR-TKI plus anti-angiogenic combination therapy [2]. Here, EGFR is linked to lung carcinoma.